| scholarly article | Q13442814 |
| P2093 | author name string | Wu WC | |
| Richter JE | |||
| Castell DO | |||
| Copper JB | |||
| Wiener GJ | |||
| P433 | issue | 4 | |
| P304 | page(s) | 358-361 | |
| P577 | publication date | 1988-04-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring | |
| P478 | volume | 83 |
| Q48055864 | 2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease. |
| Q54965815 | A Positive Reflux-Symptom Association Is Not Marked When the Onset of the Reflux Episode Does Not Occur Within the Pre-symptom Time Window. |
| Q35349753 | A prospective study of oesophageal function in patients with normal coronary angiograms and controls with angina |
| Q37330315 | Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain |
| Q43981701 | Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles |
| Q24679917 | Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring |
| Q34377504 | Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis |
| Q79280722 | Acid gastroesophageal reflux reports in infants: a comparison of esophageal pH monitoring and multichannel intraluminal impedance measurements |
| Q43184883 | Acid perfusion in the assessment of non-cardiac chest pain |
| Q70143707 | Acid perfusion test and 24-hour esophageal pH monitoring with symptom index. Comparison of tests for esophageal acid sensitivity |
| Q81142665 | Acid perfusion test: a useful test for evaluating esophageal acid sensitivity |
| Q34392126 | Acid perfusion test: does it have a role in the assessment of non cardiac chest pain? |
| Q33924407 | Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters |
| Q42689388 | Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study |
| Q37779054 | Advances in diagnostic testing for gastroesophageal reflux disease |
| Q38104580 | Advances in motility testing--current and novel approaches |
| Q48744879 | Age and body mass index: significant predictive factors for successful laparoscopic antireflux surgery |
| Q34538842 | Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications |
| Q61537811 | An evidence-based appraisal of reflux disease management--the Genval Workshop Report |
| Q37648188 | Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring |
| Q92318695 | British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring |
| Q36373664 | Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients |
| Q73562553 | Chest pain at rest in patients with coronary artery disease. Myocardial ischemia, esophageal dysfunction, or panic disorder? |
| Q42388268 | Clinical Utility of Bronchoalveolar Lavage Pepsin in Diagnosis of Gastroesophageal Reflux among Wheezy Infants. |
| Q40513349 | Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux |
| Q34547392 | Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system |
| Q68715997 | Comparison of esophageal manometry, provocative testing, and ambulatory monitoring in patients with unexplained chest pain |
| Q53669516 | Correlation between hypersensitivity induced by esophageal acid infusion and the baseline impedance level in patients with suspected gastroesophageal reflux. |
| Q64916633 | Diagnosis of GERD in typical and atypical manifestations. |
| Q68715993 | Diagnosis of chest pain of esophageal origin. A guideline of the Patient Care Committee of the American Gastroenterological Association |
| Q37882470 | Diagnosis of gastroesophageal reflux disease in infants |
| Q28204509 | Diagnosis of nutcracker esophagus, segmental or diffuse hypertensive patterns, and clinical characteristics |
| Q35113352 | Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux |
| Q58579746 | Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis |
| Q33856475 | Differences in cerebral response to esophageal acid stimuli and psychological anticipation in GERD subtypes--an fMRI study |
| Q33867351 | Disagreement between symptom-reflux association analysis parameters in pediatric gastroesophageal reflux disease investigation |
| Q81404419 | Dynamic position testing for the detection of esophageal acid reflux disease |
| Q74623035 | Dynamic position versus 24-hour pH testing for detection of esophageal acid reflux disease |
| Q84985206 | Early acid perception in NERD |
| Q39332552 | Effect of Severity of Esophageal Acidification on Sleep vs Wake Periods in Infants Presenting with Brief Resolved Unexplained Events |
| Q35598069 | Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux |
| Q53387244 | Effects of Esophageal Acidification on Troublesome Symptoms: An Approach to Characterize True Acid GERD in Dysphagic Neonates. |
| Q73867421 | Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux |
| Q36378820 | Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis |
| Q39360251 | Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease |
| Q37829303 | Esophageal impedance monitoring for gastroesophageal reflux. |
| Q34027716 | Esophageal sensitivity and symptom perception in gastroesophageal reflux disease |
| Q40158123 | Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System. |
| Q47915951 | Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. |
| Q79775335 | Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: a randomized trial |
| Q74404010 | Functional Heartburn |
| Q80356232 | Functional heartburn |
| Q34994672 | Functional heartburn: the stimulus, the pain, and the brain |
| Q37861598 | GERD-related cough: pathophysiology and diagnostic approach. |
| Q80167946 | Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux |
| Q46012235 | Gastroesophageal reflux disease (GERD) and chest pain. Results of laparoscopic antireflux surgery. |
| Q77349015 | Gastroesophageal reflux disease is a common cause of noncardiac chest pain in a country with a low prevalence of reflux esophagitis |
| Q33614081 | Gastroesophageal reflux in patients with angiographically normal coronary arteries: an uncommon cause of exertional chest pain |
| Q35563400 | High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain |
| Q33890557 | How to Interpret Ambulatory 24 hr Esophageal pH Monitoring |
| Q72313625 | How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? |
| Q39278280 | Impact of symptom–reflux association analysis on long-term outcome after Nissen fundoplication |
| Q33586834 | Impedance pH Monitoring: Intra-observer and Inter-observer Agreement and Usefulness of a Rapid Analysis of Symptom Reflux Association |
| Q37997366 | Impedance pH confirms the relationship between GERD and BMI. |
| Q42844207 | Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application? |
| Q34407577 | Importance of reflux symptoms in functional dyspepsia |
| Q41838859 | Intraesophageal pressure recording improves the detection of cough during multichannel intraluminal impedance testing in children. |
| Q33880364 | Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough |
| Q34408532 | Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD |
| Q35252692 | Maintenance therapy: is there still a place for antireflux surgery? |
| Q36219922 | Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux |
| Q27025882 | Management of the patient with incomplete response to PPI therapy |
| Q50043480 | Modern diagnosis of GERD: the Lyon Consensus |
| Q50791835 | Most GERD symptoms are not due to acid reflux in patients with very low 24-hour acid contact times. |
| Q82038916 | Obese patients have stronger peristalsis and increased acid exposure in the esophagus |
| Q51615174 | Occurrence of gastroesophageal reflux on induction of anaesthesia does not correlate with the volume of gastric contents. |
| Q35118901 | Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease |
| Q45208864 | Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux? |
| Q35534102 | Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients |
| Q87849109 | Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nu |
| Q51891572 | Performance of the Montreal Consensus in the diagnosis of gastroesophageal reflux disease in morbidly obese patients. |
| Q34393499 | Power of oesophageal peristalsis can be controlled voluntarily |
| Q37154643 | Prolonged 2-day esophageal pH-metry with impedance monitoring improves symptom-reflux association analysis |
| Q68127002 | Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis |
| Q60619306 | Prospective Study Examining the Impact of Multichannel Intraluminal Impedance on Antireflux Surgery |
| Q33868511 | Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting |
| Q90377843 | Reflux and Belching after Laparoscopic 270 degree Posterior Versus 180 degree Anterior Partial Fundoplication |
| Q40967545 | Reflux events detected by pH-MII do not determine fundoplication outcome. |
| Q37215504 | Reflux monitoring: current status |
| Q34408954 | Reflux related symptoms in patients with normal oesophageal exposure to acid |
| Q77813857 | Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant |
| Q35026352 | Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease |
| Q35995406 | Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease |
| Q38741820 | Short- and Long-Term, 11-22 Years, Results after Laparoscopic Nissen Fundoplication in Obese versus Nonobese Patients. |
| Q38985887 | Significance of gastroesophageal refluxate in relation to physical, chemical, and spatiotemporal characteristics in symptomatic intensive care unit neonates. |
| Q34409676 | Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry |
| Q73797534 | Standard acid reflux testing revisited |
| Q36311808 | Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring |
| Q35598218 | Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole |
| Q37660398 | Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease |
| Q36639685 | Symptom index P-value and symptom sensitivity index P-value to determine symptom association between apnea and reflux in premature infants at term |
| Q73565816 | Temporal correlation between chronic cough and gastroesophageal reflux disease |
| Q34379164 | Temporal relationships between episodes of non-cardiac chest pain and abnormal oesophageal function |
| Q37330321 | The Effect of Antisecretory Therapy and Study Duration on Ambulatory Esophageal pH Monitoring |
| Q36112158 | The Role of Sleep in the Modulation of Gastroesophageal Reflux and Symptoms in NICU Neonates |
| Q79991293 | The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan |
| Q33617738 | The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease |
| Q30399991 | The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing |
| Q40831317 | The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain |
| Q46723156 | The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications |
| Q81271619 | Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance |
| Q93050171 | Typical symptoms and not positive reflux-cough correlation predict cure of gastroesophageal reflux disease related chronic cough after laparoscopic fundoplication: a retrospective study |
| Q38356989 | Upper aerodigestive tract disorders and gastro-oesophageal reflux disease |
| Q89359663 | Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms |
| Q41844169 | Use of symptom indices in the management of GERD. |
| Q35139106 | Utility of ambulatory 24-hour esophageal pH and motility monitoring in noncardiac chest pain: report of 90 patients and review of the literature |
| Q36763208 | What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? |
| Q42416454 | When proton pump inhibitors fail |
| Q40894420 | pH monitoring: is it the gold standard for the detection of gastroesophageal reflux disease? |
Search more.